David Toung
Stock Analyst at Argus Research
(4.05)
# 431
Out of 5,182 analysts
133
Total ratings
60.95%
Success rate
8.99%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Upgrades: Buy | $400 | $366.77 | +9.06% | 9 | Apr 22, 2026 | |
| IART Integra LifeSciences Holdings | Downgrades: Hold | n/a | $10.74 | - | 3 | Apr 15, 2026 | |
| MDT Medtronic | Maintains: Buy | $125 → $115 | $81.90 | +40.42% | 8 | Apr 6, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $230 → $180 | $149.52 | +20.39% | 1 | Mar 23, 2026 | |
| PFE Pfizer | Upgrades: Buy | $35 | $26.48 | +32.18% | 2 | Mar 2, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $530 → $560 | $431.92 | +29.65% | 3 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $53.51 | +27.08% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $470.22 | +29.73% | 8 | Oct 29, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $229.72 | +22.75% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $362.74 | - | 4 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $59.49 | -12.59% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $197.69 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $205.61 | -39.21% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $166.79 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $339.57 | +0.13% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $835.00 | -19.76% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $82.80 | +81.16% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $874.00 | -3.89% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $68.50 | +60.58% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $259.57 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $321.43 | -3.56% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $466.64 | -31.42% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $93.86 | +43.83% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $129.26 | -41.98% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $58.26 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $110.03 | -0.03% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.00 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $186.68 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $145.50 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $227.79 | -31.95% | 4 | Mar 27, 2020 |
UnitedHealth Group
Apr 22, 2026
Upgrades: Buy
Price Target: $400
Current: $366.77
Upside: +9.06%
Integra LifeSciences Holdings
Apr 15, 2026
Downgrades: Hold
Price Target: n/a
Current: $10.74
Upside: -
Medtronic
Apr 6, 2026
Maintains: Buy
Price Target: $125 → $115
Current: $81.90
Upside: +40.42%
Becton, Dickinson and Company
Mar 23, 2026
Maintains: Buy
Price Target: $230 → $180
Current: $149.52
Upside: +20.39%
Pfizer
Mar 2, 2026
Upgrades: Buy
Price Target: $35
Current: $26.48
Upside: +32.18%
HCA Healthcare
Feb 6, 2026
Maintains: Buy
Price Target: $530 → $560
Current: $431.92
Upside: +29.65%
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $53.51
Upside: +27.08%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $470.22
Upside: +29.73%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $229.72
Upside: +22.75%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $362.74
Upside: -
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $59.49
Upside: -12.59%
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $197.69
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $205.61
Upside: -39.21%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $166.79
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $339.57
Upside: +0.13%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $835.00
Upside: -19.76%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $82.80
Upside: +81.16%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $874.00
Upside: -3.89%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $68.50
Upside: +60.58%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $259.57
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $321.43
Upside: -3.56%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $466.64
Upside: -31.42%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $93.86
Upside: +43.83%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $129.26
Upside: -41.98%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $58.26
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $110.03
Upside: -0.03%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $6.00
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $186.68
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $145.50
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $227.79
Upside: -31.95%